Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on industry transaction
Mandate

Vinge advises on industry transaction

June 29, 2010

Vinge has advised Swedwire Förvaltnings AB in connection with the sale of its subsidiary Swedwire AB to Lagerkrantz Group AB.

Swedwire develops, manufactures and markets niche steal products such as bracing wires and crash barrier wires, wire for reinforcing submarine cables and power lines. In 2009, Swedwire’s turnover amounted to approximately SEK 80 million with good profitability. The company conducts its operation in Varberg. Lagerkrantz Group AB is a technology trading company focusing on electronics, electricity, communications and related areas. Lagerkrantz Group’s shares have been listed on Nasdaq OMX Stockholm since 2001.

Vinge’s team consisted of Magnus Pauli and Emma Kero Ljungberg.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026